The night's watch: Exploring how sleep protects against neurodegeneration
- PMID: 40054454
- PMCID: PMC11925672
- DOI: 10.1016/j.neuron.2025.02.004
The night's watch: Exploring how sleep protects against neurodegeneration
Abstract
Sleep loss is often regarded as an early manifestation of neurodegenerative diseases given its common occurrence and link to cognitive dysfunction. However, the precise mechanisms by which sleep disturbances contribute to neurodegeneration are not fully understood, nor is it clear why some individuals are more susceptible to these effects than others. This review addresses critical unanswered questions in the field, including whether sleep disturbances precede or result from neurodegenerative diseases, the functional significance of sleep changes during the preclinical disease phase, and the potential role of sleep homeostasis as an adaptive mechanism enhancing resilience against cognitive decline and neurodegeneration.
Keywords: Alzheimer’s disease; inflammation; neurodegeneration; sleep; slow-wave activity.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests D.M.H. is as an inventor on a patent licensed by Washington University to C2N Diagnostics on the therapeutic use of anti-tau antibodies, US patent no. 9,834,596. D.M.H. co-founded and is on the scientific advisory board of C2N Diagnostics. D.M.H. is on the scientific advisory boards of Denali, Genentech, and Cajal Neuroscience and consults for Asteroid, Pfizer, and Roche.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical